AgingResearch.NewsJoin free

HM01

HM01 has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Nov 28, 2022: “Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects against Redox-Dependent Sarcopenia”.

Intervention

1 paper studies it1 findingUpdated

PubChem

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: National Institute on Aging and 2 more
  • Animals1

What did studies of HM01 find?

1

Studies of HM01 measured 1 outcome; the most studied are muscle mass (1 study).

Muscle mass

downin mice1

1 study

  1. HM01 decreases muscle mass in mice.

    “It also decreased lean body mass and muscle mass of wildtype and Sod1KO.”

    Animalsin wildtype and Sod1KO mice

    Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects against Redox-Dependent Sarcopenia

    Antioxidants (Basel, Switzerland)

Latest

Related